Teyi Pharmaceutical Group Co.,Ltd announced a private placement of not more than 30,000,000 A shares for gross proceeds of not more than CNY 275,000,000 on June 27, 2023. The transaction will include participation from not more than 35 designated investors. The pricing base date of this issuance is the first day of the issuance period, and the issue price shall not be lower than 80% of the company's stock trading average price in the 20 trading days prior to the pricing base date.

The shares to be issued in the transaction will have a lock-up period of 6 months after issuance completion date within which they cannot be transferred. The transaction is approved in 11th session of the company?s 5th directorate and the 10th session of the company?s 5th supervisory board. The transaction is subject to the approval of the shareholders of the company and approval of the China Securities Regulatory Commission.